Ng T, Tillyer M L
Department of Haematological Medicine, King's College Hospital, Denmark Hill, London, UK.
Clin Lab Haematol. 2001 Aug;23(4):261-4. doi: 10.1046/j.1365-2257.2001.00399.x.
Thrombotic events are rare complications during anticoagulation therapy. The thrombosis varies from localized cutaneous involvement to catastrophic thromboembolism and is usually associated with an underlying thrombophilia. We describe a patient who developed skin necrosis during warfarin treatment for a pulmonary thromboembolism. The management was complicated by the development of heparin-induced thrombocytopenia and further thrombotic events. Thrombophilia screen demonstrated the presence of protein S deficiency and Factor V Leiden as the prothrombotic factors, together with the demonstration of antiplatelet factor 4 antibodies, which confirms the diagnosis of heparin-induced thrombocytopenia (type II). Reinstitution of warfarin at a low loading dose was successful without the recurrence of skin lesions nor any further thrombosis.
血栓形成事件是抗凝治疗期间罕见的并发症。血栓形成从局部皮肤受累到灾难性血栓栓塞不等,通常与潜在的易栓症有关。我们描述了一名在接受华法林治疗肺血栓栓塞期间发生皮肤坏死的患者。治疗因肝素诱导的血小板减少症和进一步的血栓形成事件而变得复杂。易栓症筛查显示存在蛋白S缺乏和因子V莱顿作为促血栓形成因素,同时检测到抗血小板因子4抗体,这证实了肝素诱导的血小板减少症(II型)的诊断。以低负荷剂量重新使用华法林成功,未再出现皮肤病变或任何进一步的血栓形成。